NASDAQ
ZLAB

Zai Lab Ltd

PHARMACEUTICAL PREPARATIONS
LIFE SCIENCES

Prices are adjusted according to historical splits.

Zai Lab Ltd Stock Price

Vitals

Today's Low:
$25.5950
Today's High:
$28.3900
Open Price:
$26.0000
52W Low:
$20.98
52W High:
$102.43
Prev. Close:
$25.0200
Volume:
947926

Company Statistics

Market Cap.:
$2.686 billion
Book Value:
12.65
Revenue TTM:
$0.182 billion
Operating Margin TTM:
-264%
Gross Profit TTM:
$-0.481 billion
Gross Profit TTM:
$-0.481 billion
Profit Margin:
-290.1%
Return on Assets TTM:
-18.1%
Return on Equity TTM:
-36.7%

Company Profile

Zai Lab Ltd had its IPO on 2017-09-20 under the ticker symbol ZLAB.

The company operates in the LIFE SCIENCES sector and PHARMACEUTICAL PREPARATIONS industry. Zai Lab Ltd has a staff strength of 0 employees.

Stock update

Shares of Zai Lab Ltd opened at $26 at the start of the last trading session i.e. 2022-11-02.

The stocks traded within a range of $25.6 - $28.39, and closed at $27.43.

This is a +9.63% increase from the previous day's closing price.

A total volume of 947,926 shares were traded at the close of the day’s session.

In the last one week, shares of Zai Lab Ltd have increased by +14.29%.

Zai Lab Ltd's Key Ratios

Zai Lab Ltd has a market cap of $2.686 billion, indicating a price to book ratio of 1.8 and a price to sales ratio of 14.74.

In the last 12-months Zai Lab Ltd’s revenue was $0.182 billion with a gross profit of $-0.481 billion and an EBITDA of $-0.473 billion. The EBITDA ratio measures Zai Lab Ltd's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Zai Lab Ltd’s operating margin was -264% while its return on assets stood at -18.1% with a return of equity of -36.7%.

In Q2, Zai Lab Ltd’s quarterly earnings growth was a positive 0% while revenue growth was a positive 30.4%.

Zai Lab Ltd’s PE and PEG Ratio

Forward PE
-
Trailing PE
-
PEG
None

Its diluted EPS in the last 12-months stands at $-5.84 per share while it has a forward price to earnings multiple of - and a PEG multiple of None. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Zai Lab Ltd’s profitability.

Zai Lab Ltd stock is trading at a EV to sales ratio of 5.59 and a EV to EBITDA ratio of -2.137. Its price to sales ratio in the trailing 12-months stood at 14.74.

Zai Lab Ltd stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets
$0.000 billion
Total Liabilities
$0.000 billion
Operating Cash Flow
$0.000 billion
Capital Expenditure
$0.000 billion
Dividend Payout Ratio
0%

Zai Lab Ltd ended 1970 with $0.000 billion in total assets and $131.2 billion in total liabilities. Its intangible assets were valued at $0.000 billion while shareholder equity stood at $0.000 billion.

Zai Lab Ltd ended 1970 with $0.000 billion in deferred long-term liabilities, $0.000 billion in other current liabilities, billion in common stock, $0.000 billion in retained earnings and $0.000 billion in goodwill. Its cash balance stood at $0.000 billion and cash and short-term investments were $0.000 billion. The company’s total short-term debt was $0.000 billion while long-term debt stood at $0.000 billion.

Zai Lab Ltd’s total current assets stands at $0.000 billion while long-term investments were $0.000 billion and short-term investments were $0.000 million. Its net receivables were $0.000 billion compared to accounts payable of $0.000 billion and inventory worth $0.000 billion.

In 1970, Zai Lab Ltd's operating cash flow was $0.000 billion while its capital expenditure stood at $0.000 billion.

Comparatively, Zai Lab Ltd paid $0 billion in dividends in 1970.

Other key metrics

Current Trading Price
$27.43
52-Week High
$102.43
52-Week Low
$20.98
Analyst Target Price
$92.02

Zai Lab Ltd stock is currently trading at $27.43 per share. It touched a 52-week high of $102.43 and a 52-week low of $102.43. Analysts tracking the stock have a 12-month average target price of $92.02.

Its 50-day moving average was $0 and 200-day moving average was $0 The short ratio stood at indicating a short percent outstanding of 0%.

Around 0% of the company’s stock are held by insiders while 0% are held by institutions.

Frequently Asked Questions About Zai Lab Ltd

The stock symbol (also called stock or share ticker) of Zai Lab Ltd is ZLAB

The IPO of Zai Lab Ltd took place on 2017-09-20

Similar Industry Stocks (PHARMACEUTICAL PREPARATIONS)

Last Price
Chg
Chg%
$3
0.1
+3.45%
$28.12
-1.35
-4.58%
I-Mab (IMAB)
$3.65
-0.25
-6.41%
$1.08
0
0%
HUTCHMED DRC (HCM)
$8.66
0.06
+0.7%

Most Active

Last Price
Chg
Chg%
$58.63
-1.03
-1.73%
$92.12
-4.67
-4.82%
$5.12
-0.61
-10.65%
Apple Inc (AAPL)
$145.03
-5.62
-3.73%
$0.06
0.01
+12.74%

Top Gainers

Last Price
Chg
Chg%
$73
42.7
+140.92%
$0.02
0.01
+100%
Oi S.A (OIBR-C)
$0
0
+100%
$0.25
0.1
+66.44%
$2.85
1.01
+54.86%

Top Losers

Last Price
Chg
Chg%
$5.36
-22.58
-80.82%
$0.02
-0.06
-78.67%
Air T, Inc (AIRTW)
$0.01
-0.03
-75%
$4.51
-5.17
-53.41%
$11.5
-12.2
-51.48%

About

Zai Lab Limited, a biopharmaceutical company, discovers, licenses, develops and markets therapies to treat cancer, autoimmune and infectious diseases in China. The company is headquartered in Shanghai, China.

Address

4560 JINKE ROAD, BLDG. 1, 4F, PUDONG, SHANGHAI, CHINA